Clinical trial registration

Health Canada announces another step to accelerate access to health products for COVID-19

Retrieved on: 
Wednesday, May 27, 2020
Health, Articles, Design of experiments, Clinical research, Medical ethics, Clinical trial, Pharmaceutical industry, Institutional review board, Clinical trial registration, Influenza research

To date, Health Canada has approved 37 clinical trials for potential COVID-19 therapies and vaccines.

Key Points: 
  • To date, Health Canada has approved 37 clinical trials for potential COVID-19 therapies and vaccines.
  • The changes to the process for clinical trials have been made through an Interim Order signed by the Minister of Health.
  • An Interim Order is one of the fastest mechanisms available to the Government of Canada to help make health products available to address larger-scale public health emergencies.
  • Health Canada and the Canadian Institutes of Health Research, in collaboration with the Canadian Association of Research Ethics Boards, issued a Joint Statement on Clinical Trial Oversight in Canada.

CISCRP Explores the Impact of COVID-19 on Clinical Research

Retrieved on: 
Tuesday, May 26, 2020
Health, Clinical research, Medical research, Pharmaceutical industry, Clinical pharmacology, Clinical trial, Design of experiments, Clinical trial registration, Patient recruitment

In light of this, CISCRP conducted a brief survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences.

Key Points: 
  • In light of this, CISCRP conducted a brief survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences.
  • Of those who have participated in clinical research, more than half (56%) are currently enrolled in a clinical trial for COVID-19.
  • Overall, awareness of clinical trials remains low as 58% had not heard of a COVID-19 clinical research study recently.
  • The Center for Information and Study on Clinical Research Participation (CISCRP) is an internationally recognized non-profit organization dedicated to educating and informing the public and patients about clinical research.

Global Clinical Trials Review for COVID-19, H1, 2020 - ResearchAndMarkets.com

Retrieved on: 
Friday, May 1, 2020
Infectious diseases, Pharmaceutical, Health, Clinical trials, Health, Clinical research, Medical research, Pharmaceutical industry, Coronaviridae, Clinical trial registration, World Health Organization, Coronavirus, Clinical trials

The "Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020" report has been added to ResearchAndMarkets.com's offering.
  • The clinical trial report, "Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020" provides an overview of Hyperthyroidism Clinical trials scenario.
  • Clinical Trial Reports are generated using the publisher's proprietary database - Pharma eTrack Clinical trials database.
  • Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.

Global Review of Alcohol Addiction Clinical Trials, H1 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 14, 2020
Health, Clinical trials, Health, Clinical research, Medical research, Pharmaceutical industry, Clinical trials, Clinical trial registration, World Health Organization, Clinical trials

The "Alcohol Addiction Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Alcohol Addiction Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.
  • This report provides top line data relating to clinical trials on Alcohol Addiction.
  • The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
  • Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.

Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 14, 2020
Health, Clinical trials, Clinical research, Health, Medical research, Pharmaceutical industry, Articles, Food and Drug Administration, Clinical trial registration, World Health Organization, Clinical trial

The "Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.
  • This report provides top line data relating to clinical trials on Neonatal Respiratory Distress Syndrome and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
  • Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.
  • It provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
    It reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
    The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
    Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
    Facilitates clinical trial assessment of the indication on a global, regional and country level
    Clinical Trials by G7 Countries: Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials
    Clinical Trials by E7 Countries: Proportion of Neonatal Respiratory Distress Syndrome to Respiratory Clinical Trials

As Universities and Academic Institutions Face Unique Challenges in Reporting Clinical Trials, TrialAssure Responds by Offering Free Clinical Trial Transparency Tool

Retrieved on: 
Tuesday, April 7, 2020
Data management, Health, Technology, Software, Clinical trials, Research, Science, Articles, Health, Clinical research, Medical research, Free software, Humanities, Transparency, Clinical trial, Clinical trial registration

TrialAssure a leading, global software company focused on developing clinical trial transparency tools announced today that it will offer academic institutions free access to TrialAssure REGISTRYthe premiere clinical trial disclosure reporting application.

Key Points: 
  • TrialAssure a leading, global software company focused on developing clinical trial transparency tools announced today that it will offer academic institutions free access to TrialAssure REGISTRYthe premiere clinical trial disclosure reporting application.
  • Academic institutions can sign up for a TrialAssure subscription specific to this programat no cost allowing users free access for up to two years.
  • TrialAssure, in providing access to the REGISTRY application, will ask participating academic institutions to make a commitment to transparency in research, including measured improvements to their registry compliance over a two-year period.
  • With this free, limited-time academic subscription program, institutions will have up to three professional and 20 reviewer level users within the TrialAssure REGISTRY application.

TrialScope Launches Website as Free Resource for Researchers, Patients on COVID-19 Trials

Retrieved on: 
Tuesday, March 24, 2020
Health, Clinical research, Medical research, Clinical trials, Pharmaceutical industry, National Institutes of Health, ClinicalTrials.gov, Clinical pharmacology, United States National Library of Medicine, Clinical trial registration, IFPMA Clinical Trials Portal

In an effort to provide an up-to-the-minute source of credible clinical trial information, TrialScope has launched CoronaClinicalTrials.com .

Key Points: 
  • In an effort to provide an up-to-the-minute source of credible clinical trial information, TrialScope has launched CoronaClinicalTrials.com .
  • The website automatically syncs clinical trial information from ClinicalTrials.gov, the national registry of clinical trials.
  • Established by the United States National Library of Medicine at the National Institutes of Health, it houses the largest database of clinical trials.
  • CoronaClinicalTrials.com features a robust search engine, powered by TrialScope technology, that enables site visitors to search for COVID-19 clinical trials by keyword or location.

Effepharm Started New Clinical Trials on Uthever™

Retrieved on: 
Thursday, February 6, 2020
Biotechnology, Pharmaceutical, Health, Health, Clinical research, Medical research, Articles, Life extension, Nicotinamide mononucleotide, Nucleotides, NMN, Clinical trial registration, Clinical trials

Effepharm Ltd declared new clinical trials on UtheverTM - its branded NMN(Nicotinamide Mononucleotide) ingredient recently.

Key Points: 
  • Effepharm Ltd declared new clinical trials on UtheverTM - its branded NMN(Nicotinamide Mononucleotide) ingredient recently.
  • The clinical trial on UtheverTM is the largest scaletrial on NMN in the world according to ICTRP(WHOs International Clinical Trials Registry Platform).
  • Effepharm is the first and the only NMN ingredient manufacturer until now to conduct clinical trials in the world.
  • We believe UtheverTM will stand the test of time and become the golden standard of NMN, said Dr. Yu, R&D director at Effepharm.

Triple-Negative Breast Cancer Global Clinical Trials Review, H2, 2019 - Pfizer Inc, Novartis AG, Eisai Co Ltd & Bayer AG - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 30, 2020
Health, Oncology, Clinical trials, Health, Clinical research, Medicine, Medical research, Triple-negative breast cancer, Clinical trial registration, Clinical trials, Breast cancer, Triple Negative Breast Cancer Foundation, Glembatumumab vedotin

The "Triple-Negative Breast Cancer (TNBC) Global Clinical Trials Review, H2, 2019" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Triple-Negative Breast Cancer (TNBC) Global Clinical Trials Review, H2, 2019" clinical trials has been added to ResearchAndMarkets.com's offering.
  • The clinical trial report, Triple-Negative Breast Cancer (TNBC) Global Clinical Trials Review, H2, 2019 provides an overview of Triple-Negative Breast Cancer (TNBC) clinical trials scenario.
  • The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
  • Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.

TrialAssure launches TrialResults.com for Clinical Trial Sponsors to Publicly Post Plain Language Summaries

Retrieved on: 
Tuesday, June 11, 2019
Seniors, Technology, Data management, Software, Other Technology, Health, Clinical trials, Small business, Professional services, Consulting, Other Professional Services, Research, Other Science, Consumer, Science, General Health, Clinical research, Health, Medical research, Articles, Clinical trial registration, Clinical trial, IFPMA Clinical Trials Portal

TrialAssure a leading, global software company focused on developing clinical trial transparency tools announced today the launch of TrialResults.com, a new portal for sponsors to publicly share plain language, or lay, summaries with clinical trial participants.

Key Points: 
  • TrialAssure a leading, global software company focused on developing clinical trial transparency tools announced today the launch of TrialResults.com, a new portal for sponsors to publicly share plain language, or lay, summaries with clinical trial participants.
  • In place of mailing paper copies of the plain language summaries to participants, sponsors can simply upload the summary onto the portal, saving both time and money.
  • Currently, only 2 percent of clinical trial sponsors have issued plain language summaries to participants in the past few years, as recently reported by Applied Clinical Trials.
  • For many trial participants, trying to understand the clinical trial results as posted to government clinical trial registries can be difficult, given the highly technical scientific jargon.